José Manuel Zubeldia

Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial

Jonathan O’B Hourihane, Kirsten Beyer, Allyah Abbas‐Hanif et al. · The Lancet Child & Adolescent Health · 2020 · 158 citations

Life Sciences, Immunology, Pediatrics +14

Fluorescein-Induced Allergic Reaction

María Pilar López-Sáez, E. Ordoqui, P. Tornero et al. · Annals of Allergy Asthma & Immunology · 1998 · 116 citations

Inhibition of Chronic Airway Inflammation and Remodeling by Galectin-3 Gene Therapy in a Murine Model

Esther López, Victoria del Pozo, Teresa Miguel et al. · The Journal of Immunology · 2006 · 90 citations · Full text

Veterinary Medicine, Immunology, Pharmacology +14

Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study

Brian P. Vickery, Andrea Vereda, Caroline Nilsson et al. · The Journal of Allergy and Clinical Immunology In Practice · 2020 · 90 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Systemic Administration of Immunostimulatory DNA Sequences Mediates Reversible Inhibition of Th2 Responses in a Mouse Model of Asthma

David H. Broide, Greg Stachnick, Diego Castaneda et al. · Journal of Clinical Immunology · 2001 · 86 citations

Life Sciences, Immunology, Pharmacology +15